De novo acute myeloid leukemia risk factors

被引:37
|
作者
Strom, Sara S. [1 ]
Oum, Robert
Gbito, Kplola Y. Elhor
Garcia-Manero, Guillermo [2 ]
Yamamura, Yuko
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
acute myeloid leukemia; epidemiology; risk factors; smoking; solvents; obesity; BODY-MASS INDEX; CIGARETTE-SMOKING; ADULT LEUKEMIA; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL EXPOSURE; LIFE-STYLE; BENZENE; MORTALITY; FEATURES; TOBACCO;
D O I
10.1002/cncr.27442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Acute myeloid leukemia (AML) is comprised of several bone marrow-based cancers and is the most common type of leukemia in the United States. The etiology of AML is not well understood. A case-control study was conducted at The University of Texas M. D. Anderson Cancer Center to investigate associations between lifestyle characteristics and the risk of AML in Texas. METHODS: This study included 638 adult patients with de novo AML (cases) and a group of 636 matched controls. Interviewer-administered questionnaires were used to collect demographic and occupational data. The distribution of cases by World Health Organization (WHO) subtype was 71 patients (11%) with recurrent cytogenetic abnormalities (AML-RCA), 134 patients (21%) with multilineage dysplasia (AML-MD), and 389 patients (61%) with AML not otherwise categorized (AML-NOC). Multivariate logistic regression analyses were performed among all AML cases and among both sexes and each WHO subgroup. RESULTS: Among men, heavy smoking (=30 pack-years; odds ratio [OR], 1.86) and occupational solvent exposure at low levels (OR, 2.87) or moderate/high levels (OR, 4.13) statistically significantly increased the risk of AML. Among women, obesity (OR, 1.62) and solvent exposure to low levels (OR, 2.73) or moderate/high levels (OR, 3.90) increased the risk of AML. Across WHO subtypes, obesity was associated with a statistically significantly increased risk of AML-RCA (OR, 3.15), whereas solvent exposure increased the risk in all subtypes at low levels (AML-RCA: OR, 4.11; AML-MD: OR, 2.54) and moderate/high levels (AML-RCA: OR, 5.13; AML-MD: OR, 3.02). A joint effect between smoking and solvent exposure was observed, and the highest risk was observed among smokers who had solvent exposure (OR, 4.51). CONCLUSIONS: The current results suggested that several factors play a role in AML predisposition with possible joint effects. Risk profiles for AML differed by sex and WHO subtype. Cancer 2012.(c) 2012 American Cancer Society.
引用
收藏
页码:4589 / 4596
页数:8
相关论文
共 50 条
  • [1] Changes in the hierarchy of risk factors with older age in de-novo acute myeloid leukemia (AML).
    Buchner, Thomas
    Berdel, Wolfgang E.
    Schoch, Claudia
    Haferlach, Torsten
    Serve, Hubert L.
    Kienast, Joachim
    Schnittger, Susanne
    Kern, Wolfgang
    Tchinda, Joelle
    Reichle, Albrecht
    Staib, Peter
    Ludwig, Wolf-Dieter
    Aul, Carlo
    Sauerland, Maria Cristina
    Heinecke, Achim
    Wormann, Bernhard Josef
    Hiddemann, Wolfgang
    BLOOD, 2006, 108 (11) : 559A - 560A
  • [2] MOLECULAR MARKERS IN DE NOVO ACUTE MYELOID LEUKEMIA
    Salem, K.
    Alkhail, H. Aba
    HAEMATOLOGICA, 2014, 99 : 567 - 568
  • [3] RNA expression-based risk stratification of de novo acute myeloid leukemia
    Kim, Donghyun
    Yu, Yeonhwa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Philadelphia Chromosome Positive de novo Acute Myeloid Leukemia
    Quraishi, Arif Moin
    Akram, Muhammad
    Saeed, Sarah
    Tahir, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (11): : S100 - S102
  • [5] De novo acute myeloid leukemia with monocytoid blasts and erythrophagocytosis
    Blieden, Clifford
    Fan, Yao-Shan
    Chapman, Jennifer Rose
    Vega, Francisco
    CLINICAL CASE REPORTS, 2014, 2 (06): : 333 - 335
  • [6] Clinical challenges in de novo pediatric acute myeloid leukemia
    Klein, Kim
    de Haas, Valerie
    Kaspers, Gertjan J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 277 - 293
  • [7] Proteomic Landscape of De Novo Pediatric Acute Myeloid Leukemia
    Hoff, Fieke W.
    Qiu, Yihua
    Hu, Wendy
    Qutub, Amina A.
    Gamis, Alan S.
    Aplenc, Richard
    Kolb, E. Anders
    Alonzo, Todd A.
    de Bont, Eveline S.
    Horton, Terzah M.
    Kornblau, Steven M.
    BLOOD, 2018, 132
  • [8] Nucleophosmin mutation in de-novo acute myeloid leukemia
    Rastogi, Pulkit
    Naseem, Shano
    Varma, Neelam
    Varma, Subhash
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : 77 - 85
  • [9] Comorbidity and age as risk factors for survival in de novo acute leukemia.
    Lichtman, SM
    Kolitz, J
    Cirrone, K
    Zaheer, W
    Spinek, K
    Weisman, A
    Schulman, P
    BLOOD, 1996, 88 (10) : 3390 - 3390
  • [10] Proteomic landscape of de novo pediatric acute myeloid leukemia
    Hoff, Fieke W.
    Qiu, Yihua
    Hu, Wendy
    Qutub, Amina A.
    Gamis, Alan S.
    Aplenc, Richard
    Kolb, E. Anders
    Alonzo, Todd A.
    de Bont, Eveline S. J. M.
    Horton, Terzah M.
    Kornblau, Steven M.
    CANCER RESEARCH, 2018, 78 (13)